Last reviewed · How we verify

NCT05669937

Validity and Reliability of the Baby Preparation and Worry Scale

Completed Last updated 3 January 2023
What this trial tests

trial in Mothers in 220 participants. Completed in 1 October 2022.

Timeline
1 January 2022
Primary endpoint
1 July 2022
1 October 2022

Quick facts

Lead sponsorMevlüde Alpaslan Arar
StatusCompleted
Study typeOBSERVATIONAL
Enrollment220
Start date1 January 2022
Primary completion1 July 2022
Estimated completion1 October 2022
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Mevlüde Alpaslan Arar

Who can join

Adults 18 to 45, female only, with Mothers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Reliable and valid measurement tools are needed to capture key components of prenatal distress, including anxiety and anxiety states that may put women and children at increased risk in the postpartum period. Aim: The aim of this study is to determine the validity and reliability of the Baby Preparation and Worry Scale (Baby-PAWS), by adapting it to Turkish culture. .

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Mothers

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05669937.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing